Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

LUQUET

Showing results (391-400 of 412) with videos related to

Pageof 42
Sort By:
Blood|February 18, 2010
Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique studyEtienne Coyaud, Stephanie Struski, Nais Prade, et al.
Cell Metabolism|March 7, 2020
Circulating Triglycerides Gate Dopamine-Associated Behaviors through DRD2-Expressing NeuronsChloé Berland, Enrica Montalban, Elodie Perrin, et al.
Diabetes|September 19, 2019
MCH Regulates SIRT1/FoxO1 and Reduces POMC Neuronal Activity to Induce Hyperphagia, Adiposity, and Glucose IntoleranceOmar Al-Massadi, Mar Quiñones, Jerome Clasadonte, et al.
Haematologica|February 6, 2025
Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02)Sarah Bertoli, Emilie Bérard, Pierre Peterlin, et al.
Leukemia|September 18, 2020
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO studyLaetitia Largeaud, Pascale Cornillet-Lefebvre, Jean-François Hamel, et al.
Blood Cancer Journal|June 3, 2017
Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trialM Hunault-Berger, N Maillard, C Himberlin, et al.
Leukemia|February 10, 2006
NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique HématologiqueS P Romana, I Radford-Weiss, R Ben Abdelali, et al.
British Journal of Haematology|December 14, 2020
Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalitiesBaptiste Gailllard, Pascale Cornillet-Lefebvre, Quoc-Hung Le, et al.
Genes, Chromosomes & Cancer|April 15, 2014
14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphomaAdrien Cosson, Elise Chapiro, Nabila Belhouachi, et al.
Haematologica|December 22, 2018
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemiaAudrey Bidet, Stéphanie Dulucq, Thomas Smol, et al.
Pageof 42

Showing results (391-400 of 412) with videos related to

Sort By:
Pageof 42
Blood|February 18, 2010
Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique studyEtienne Coyaud, Stephanie Struski, Nais Prade, et al.
Cell Metabolism|March 7, 2020
Circulating Triglycerides Gate Dopamine-Associated Behaviors through DRD2-Expressing NeuronsChloé Berland, Enrica Montalban, Elodie Perrin, et al.
Diabetes|September 19, 2019
MCH Regulates SIRT1/FoxO1 and Reduces POMC Neuronal Activity to Induce Hyperphagia, Adiposity, and Glucose IntoleranceOmar Al-Massadi, Mar Quiñones, Jerome Clasadonte, et al.
Haematologica|February 6, 2025
Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02)Sarah Bertoli, Emilie Bérard, Pierre Peterlin, et al.
Leukemia|September 18, 2020
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO studyLaetitia Largeaud, Pascale Cornillet-Lefebvre, Jean-François Hamel, et al.
Blood Cancer Journal|June 3, 2017
Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trialM Hunault-Berger, N Maillard, C Himberlin, et al.
Leukemia|February 10, 2006
NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique HématologiqueS P Romana, I Radford-Weiss, R Ben Abdelali, et al.
British Journal of Haematology|December 14, 2020
Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalitiesBaptiste Gailllard, Pascale Cornillet-Lefebvre, Quoc-Hung Le, et al.
Genes, Chromosomes & Cancer|April 15, 2014
14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphomaAdrien Cosson, Elise Chapiro, Nabila Belhouachi, et al.
Haematologica|December 22, 2018
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemiaAudrey Bidet, Stéphanie Dulucq, Thomas Smol, et al.
Pageof 42